Understanding how ribosomes interact with various compounds is crucial in drug development, especially for antibiotics and anti-cancer drugs. Many antibiotics, such as tetracycline and erythromycin, function by targeting bacterial ribosomes, inhibiting protein synthesis and thereby killing or inhibiting bacterial growth. Additionally, insights into ribosomal structure and function have guided the development of novel therapeutic agents that can target specific components of ribosomes to treat diseases.
